Whether EBNA3A/EBNA3C expression can eventually be turned off in long-term tumor-derived cell lines (perhaps in conjunction with epigenetic-mediated repression of BIM expression) and whether other EBV-encoded proteins and/or RNAs are also required for survival of the tumor-derived cell lines, will be an important area for future studies. This evidence concerns the gene BCL2L11 and neoplasm.